Cargando…

PB2267: COVID-19 OUTCOMES ON HAEMATOLOGY PATIENTS WHO RECEIVED RITUXIMAB: SINGLE CENTRE STUDY

Detalles Bibliográficos
Autores principales: Hariharan, L., Champion-Homfray, M., Hassan, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429346/
http://dx.doi.org/10.1097/01.HS9.0000851896.06372.76
_version_ 1784779411900334080
author Hariharan, L.
Champion-Homfray, M.
Hassan, E.
author_facet Hariharan, L.
Champion-Homfray, M.
Hassan, E.
author_sort Hariharan, L.
collection PubMed
description
format Online
Article
Text
id pubmed-9429346
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94293462022-08-31 PB2267: COVID-19 OUTCOMES ON HAEMATOLOGY PATIENTS WHO RECEIVED RITUXIMAB: SINGLE CENTRE STUDY Hariharan, L. Champion-Homfray, M. Hassan, E. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429346/ http://dx.doi.org/10.1097/01.HS9.0000851896.06372.76 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Hariharan, L.
Champion-Homfray, M.
Hassan, E.
PB2267: COVID-19 OUTCOMES ON HAEMATOLOGY PATIENTS WHO RECEIVED RITUXIMAB: SINGLE CENTRE STUDY
title PB2267: COVID-19 OUTCOMES ON HAEMATOLOGY PATIENTS WHO RECEIVED RITUXIMAB: SINGLE CENTRE STUDY
title_full PB2267: COVID-19 OUTCOMES ON HAEMATOLOGY PATIENTS WHO RECEIVED RITUXIMAB: SINGLE CENTRE STUDY
title_fullStr PB2267: COVID-19 OUTCOMES ON HAEMATOLOGY PATIENTS WHO RECEIVED RITUXIMAB: SINGLE CENTRE STUDY
title_full_unstemmed PB2267: COVID-19 OUTCOMES ON HAEMATOLOGY PATIENTS WHO RECEIVED RITUXIMAB: SINGLE CENTRE STUDY
title_short PB2267: COVID-19 OUTCOMES ON HAEMATOLOGY PATIENTS WHO RECEIVED RITUXIMAB: SINGLE CENTRE STUDY
title_sort pb2267: covid-19 outcomes on haematology patients who received rituximab: single centre study
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429346/
http://dx.doi.org/10.1097/01.HS9.0000851896.06372.76
work_keys_str_mv AT hariharanl pb2267covid19outcomesonhaematologypatientswhoreceivedrituximabsinglecentrestudy
AT championhomfraym pb2267covid19outcomesonhaematologypatientswhoreceivedrituximabsinglecentrestudy
AT hassane pb2267covid19outcomesonhaematologypatientswhoreceivedrituximabsinglecentrestudy